Background & Aims: Low serum 25-hydroxyvitamin D (25OHD) is common in obese
| INTRODUC TI ON
Vitamin D is a fat-soluble vitamin which can be obtained from diet, but mainly produced endogenously in the skin from 7-dehydrocholesterol upon UV-B radiation.
1,2 25OHD is a major circulating form of vitamin D and its serum concentration is considered as a valid biomarker for vitamin D status in human. 3 Serum 25OHD concentration below 50 nmol/L is defined as vitamin D deficiency. 4 Vitamin D deficiency is considered as a pandemic in the world, and it is estimated that around one billion people worldwide suffered from vitamin D deficiency in 2014. 5, 6 There are a number of observational studies as well as meta-analysis indicating the link between vitamin D deficiency and several metabolic disorders such as obesity; [7] [8] [9] [10] [11] high prevalence of low serum 25OHD concentration has been reported in obese people. Also, it has been reported that body fat mass is inversely related to serum 25OHD, and this association is stronger than that between 25OHD and body mass index (BMI) and body weight. 12 Obesity that is characterized by hypertrophy or/and hyperplasia of adipose tissue contributes to inflammatory complications;
this is called "meta-inflammation", [13] [14] [15] a phenomenon characterized by low-grade metabolic inflammation and chronic inflammatory response as a result of increased macrophage accumulation and release of adipokines, cytokines and chemokines such as leptin, resistin, tumour necrosis factor (TNF-α), interleukins (IL-6,IL-8,IL-1β) and monocyte chemoattractant protein (MCP-1). [16] [17] [18] [19] Several studies have shown that large adipocytes produce more pro-inflammatory adipocytokines, and weight loss associated with reduced adipocytes size, has beneficial effects on secretion patterns of inflammatory factors. 17, 20 The greatest and more consistent improvements are noted in those studies achieving at least a 10% weight loss. 21 Vitamin D has been found to have anti-adipogenic activity and may exert immune-regulatory effects, reducing the adipose tissue inflammation. 22 are able to augment TLR-4, which in turn induces activation of NFκB pathway leading to cytokine production. 27, 28 Due to the association between vitamin D deficiency and obesity, and since meta-inflammation plays a significant role in obesity pathogenesis, we hypothesized that an increase in serum 25OHD levels would reduce fat mass and meta-inflammation in obese individuals. The purpose of the this study was to investigate the effects of vitamin D3 supplementation (50 000 IU/week) compared to placebo on weight, fat mass and meta-inflammation during a 12-weeks weight loss diet programme in obese subjects with vitamin D deficiency. Compliance was assessed by counting the remaining pearls in the containers returned by the participants at the end of the study.
The primary outcome of the trial was the changes in meta-inflammation, and the secondary outcomes were changes in weight, body fat, vitamin D, calcium and PTH concentration
| Sample size calculation
The sample size was determined under the supervision of statistics expert. The data obtained from the Wamberg et al study 29 include
the mean and standard deviation of the MCP-1 variable. Taking 95% confidence and 80% test power using the following formula:
(Considering α = 0.05 and β = 0.20)
The minimum sample size in each group was 20, in order to increase the statistical power by taking 10% dropout, increased to 22 in each group.
| Measurements
Height and weight were measured to the nearest 0.1 cm and 0.1 kg with light clothes and no shoes using a calibrated stadiometerscale (Seca, Hamburg, Germany). BMI was calculated as weight (kg) divided by squared height (m 2 ). Total body fat mass was measured with Omron body analyzer according to the manufacturer's manual (model BF511; Kyoto, Japan).
Fasting (12 hours) venous blood sample (10 mL) was collected and sera of the samples were separated by centrifuge and stored at −80°C until the day of analysis High sensitivity enzyme-linked immunosorbent assay (ELISA) kit (Crystal Day, Shanghai, China) was used to measure serum levels of IL-1β (normal range 0.02-6 pg/mL, intra-assay variation, 5.8%, inter-assay variation, 9.06%, sensitivity = 0.01 pg/mL), TLR-4 (normal range 0.05-15 ng/mL, intra-assay variation, 4.58%, inter-assay variation, 7.8%, sensitivity = 0.027 ng/mL), MCP-1 (normal range 5-1500 pg/mL, intra-assay variation <6.8%, The assay sensitivity was 0.22 mmol/L, and intra-and inter-assay coefficients of variation were 3.2% and 4.1%, respectively. The analyses were performed according to the manufacturer's manual. We assessed dietary intakes of the patients using a three-day food record at baseline, weeks 6 and 12. Diet records were analysed by Nutritionist IV software (First Databank Inc, Hearst Corp., San Bruno, CA). A valid pre-tested questionnaire was completed by the participants to record information about duration of sun exposure. The participants were asked to recall the number of minutes/ hour that they had spent in daylight during the last 7 days. 30 The
International Physical Activity Questionnaire (IPAQ; short form, last 7 days) was also completed at baseline. Physical activity was estimated as light, moderate or high according to the scoring protocol.
31
Compliance = Number of capsules remaining − Total number of capsules in the sealed bottles Total number of capsules in the sealed bottles
| Statistical analysis
Numerical variables were presented as mean ± standard deviation (SD) and categorical variables were presented as frequency (percentage). Normality of data was examined by Kolmogorov-Smirnov test.
All data had normal distribution, therefore parametric tests were performed; independent samples t test (continuous variables) and chi-square test (categorical variable) were applied for comparison of baseline data between the two groups, and paired samples t test was used for assessment of intragroup changes before and after the study.
Between-groups differences were analysed at the end of the study using analysis of covariance (ANCOVA) adjusted for baseline values and covariates. P value < 0.05 was considered statistically significant. All statistical analyses were performed by IBM-SPSSStatistics Ver. 23.0 (IBM, Armonk, NY).
| Ethics
The present study was approved by Ethics Committee of 
| RE SULTS
One hundred and thirty-three obese subjects were recruited and screened for vitamin D status. Only obese subjects were eligible to participate in the study. Forty-four patients were selected and completed the trial; no subjects were dropped out of analyses. No serious adverse events, related to vitamin D 3 supplementation or weight loss programme, were found in the groups. The compliance to the 12-week supplementation for both groups was 97%. The baseline characteristics of the study population are shown in In between-group analysis, a significant difference was observed for PTH concentration at the end of the study (P = 0.007). The mean of calcium and phosphorus was not different within or between the study groups after the intervention (P > 0.05).
As shown in Table 2 , a significant decrease was found in weight, BMI and fat mass in both groups during the 12-weeks weight loss programme (P < 0.001); the difference in weight and fat mass reduction was statistically significant between the groups (P < 0.05).
After the 12-week intervention, meta-inflammation biomarkers 
| D ISCUSS I ON
In this randomized placebo-controlled trial, we found that 12 weeks of 50 000 IU vitamin D supplementation as a bolus per week, in combination weight loss diet programme (calorie restriction) reduced MCP-1 circulating levels compared to placebo and had no effect on circulating levels of IL-1β and TLR-4.
The chemokine MCP-1 has been reported to be a critical factor in promoting recruitment of monocytes into adipose tissue. when stratified by weight loss; loss at least 10% of body weight was related to more decrease in IL-1β. 35 This study showed that weight loss and vitamin D supplementation may act synergistically to reduce levels of IL-1β.
There are a number of cross-sectional studies which have reported that serum 25OHD was inversely associated with weight and fat mass. [9] [10] [11] [12] 36 In the present study, we found sup- Also, our findings indicated that serum 25OHD levels increasing from around 28 to 65 nmol/L over a 12 week period along with weight loss diet programme improved weight loss and decreased fat mass compared to the placebo group. The strengths of our study included its randomized, double-blind, placebo-controlled design, and the use of both 25OHD and PTH to document the success of our intervention. Our participants were selected from community population including both genders male and female.
There was no significant difference between the two groups in terms of gender distribution. Therefore, our results may be more generalizable to community population compared to those from studies focusing on people with specific diseases. Also, the study was conducted in winter months, and sun exposure was considered as a confounding factor. Finally, to our knowledge, no other studies had assessed the effects of vitamin D on TLR-4 in a randomized controlled clinical study in meta-inflammation, although there were a number of studies that investigated the effect of vitamin D on TLR-4 in microbial and acute inflammation.
TLR4 is described as a molecular link between free fatty acids, inflammation and the innate immune system. Saturated free fatty acids which are elevated in obesity are able to augment TLR-4 induced cytokine production.
This study had some limitations as well. All subjects received weight loss intervention; thus, we were unable to determine inde- 
| CON CLUS IONS
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